Status:
RECRUITING
Observational Cross-reactivity Study for Colorectal Cancer Diagnosis
Lead Sponsor:
ADVANCED MARKER DISCOVERY S.L.
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this observational study is to evaluate the false positive rate of the blood test based on molecular biomarkers and risk factors. A total of 250 patients diagnosed with various cancer...
Eligibility Criteria
Inclusion
- Patients older than 18 years of age at the time of blood sample collection.
- Subjects must be able to understand the information provided on the participant information sheet, must consent to participate in the study, and must sign the informed consent form.
- Patients diagnosed with only one type of cancer (no colorectal cacner) or gastrointestinal disease.
Exclusion
- Patients who have received previous chemotherapy or radiotherapy.
- In case of diagnosis of a tumor: patients who have undergone total or partial surgical resection of the tumor.
- Patients with a personal history of advanced or non-advanced colorectal adenoma, serrated lesions, colorectal cancer, familial adenomatous polyposis or Lynch syndrome.
- Patients without appropriate staging or diagnosis.
- Patients with hemolyzed plasma.
Key Trial Info
Start Date :
April 17 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06889844
Start Date
April 17 2023
End Date
December 1 2025
Last Update
October 1 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospitales HM de Malaga
Málaga, Andalusia, Spain
2
Hospital Centro Médico Asturias
Oviedo, Cantabria, Spain
3
Hospital Universitario de Ourense
Ourense, Galicia, Spain
4
Hospital Universitario HM Sanchinarro
Madrid, Madrid, Spain